{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:26:24Z","timestamp":1788175584135,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cca.2023.117243","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T20:24:57Z","timestamp":1675455897000},"page":"117243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The clinical utility of CD163 in viral diseases"],"prefix":"10.1016","volume":"541","author":[{"given":"Yi-Jing","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooi-Fong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazaly","family":"AbuBakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sing-Sin","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Shunmugarajoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Harng","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Misbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Kashfi","family":"Ab Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117243_b0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117243_b0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cca.2023.117243_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli","volume":"67","author":"Buechler","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2023.117243_b0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2008-07-167064","article-title":"The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria","volume":"113","author":"Fabriek","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117243_b0025","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00705-003-0188-4","article-title":"Expression of porcine CD163 on monocytes\/macrophages correlates with permissiveness to African swine fever infection","volume":"148","author":"Sanchez-Torres","year":"2003","journal-title":"Arch. Virol"},{"key":"10.1016\/j.cca.2023.117243_b0030","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.molimm.2010.02.008","article-title":"Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy","volume":"47","author":"Van Gorp","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.atherosclerosis.2009.04.033","article-title":"The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis","volume":"207","author":"Moreno","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2023.117243_b0040","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","article-title":"A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications","volume":"178","author":"Bover","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0045","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1089\/ars.2012.4834","article-title":"CD163 and inflammation: biological, diagnostic, and therapeutic aspects","volume":"18","author":"Etzerodt","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cca.2023.117243_b0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.imbio.2009.05.003","article-title":"Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding","volume":"215","author":"Moller","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.cca.2023.117243_b0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5603\/FHC.2011.0052","article-title":"CD163 and its role in inflammation","volume":"49","author":"Kowal","year":"2011","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.cca.2023.117243_b0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/ars.2009.2792","article-title":"Hemoglobin and heme scavenger receptors","volume":"12","author":"Nielsen","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cca.2023.117243_b0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/07853890410033171","article-title":"CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response","volume":"36","author":"Moestrup","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.cca.2023.117243_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155497","article-title":"Targeting of CD163(+) macrophages in inflammatory and malignant diseases","volume":"21","author":"Skytthe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2023.117243_b0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1373\/clinchem.2010.154724","article-title":"Serum soluble CD163 predicts risk of type 2 diabetes in the general population","volume":"57","author":"Moller","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2023.117243_b0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2005.05.004","article-title":"The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis","volume":"184","author":"Aristoteli","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2023.117243_b0085","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10875-020-00950-z","article-title":"Biomarkers for early diagnosis of hemophagocytic lymphohistiocytosis in critically Ill patients","volume":"41","author":"Debaugnies","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0090","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","volume":"326","author":"Wong","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2023.117243_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062967","article-title":"Do COVID-19 infections result in a different form of secondary hemophagocytic lymphohistiocytosis","volume":"22","author":"Chu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2023.117243_b0100","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(02)11772-7","article-title":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?","volume":"360","author":"Cheung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2023.117243_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1309\/AJCP35KOZSAVNQZW","article-title":"Autopsy findings in eight patients with fatal H1N1 influenza","volume":"134","author":"Harms","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2023.117243_b0110","doi-asserted-by":"crossref","first-page":"e2005","DOI":"10.1002\/rmv.2005","article-title":"Dengue hemophagocytic syndrome: a systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors","volume":"28","author":"Giang","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.cca.2023.117243_b0115","first-page":"1106","article-title":"Infection-associated hemophagocytic syndrome among patients with dengue shock syndrome and invasive aspergillosis: a case series and review of the literature","volume":"42","author":"Larbcharoensub","year":"2011","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.cca.2023.117243_b0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1089\/vim.2015.0040","article-title":"Elevated plasma soluble CD14 levels correlate with the monocyte response status during hantaan virus infection in humans","volume":"28","author":"Tang","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1006\/bbrc.1999.0866","article-title":"Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily","volume":"260","author":"Ritter","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2023.117243_b0130","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jlb.66.5.858","article-title":"Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation","volume":"66","author":"Van den Heuvel","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2023.117243_b0135","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jcp.44.11.936","article-title":"Ber-MAC3: new monoclonal antibody that defines human monocyte\/macrophage differentiation antigen","volume":"44","author":"Backe","year":"1991","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2023.117243_b0140","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.4049\/jimmunol.162.9.5230","article-title":"The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation","volume":"162","author":"Sanchez","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0145","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ki.2011.217","article-title":"Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis","volume":"80","author":"Anders","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2023.117243_b0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0625.1994.tb00287.x","article-title":"Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro","volume":"3","author":"Kodelja","year":"1994","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cca.2023.117243_b0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.imbio.2006.05.019","article-title":"CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes","volume":"211","author":"Maniecki","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.cca.2023.117243_b0160","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nature11369","article-title":"Structure of the haptoglobin-haemoglobin complex","volume":"489","author":"Andersen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117243_b0165","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2008-08-174466","article-title":"Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification","volume":"113","author":"Buehler","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117243_b0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1182\/blood-2005-03-1014","article-title":"CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin","volume":"107","author":"Schaer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117243_b0175","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2362.2006.01617.x","article-title":"Influence of clinical factors on the haemolysis marker haptoglobin","volume":"36","author":"Kormoczi","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cca.2023.117243_b0180","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.4049\/jimmunol.1202648","article-title":"CD163 and IgG codefend against cytotoxic hemoglobin via autocrine and paracrine mechanisms","volume":"190","author":"Subramanian","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0185","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","article-title":"Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes","volume":"109","author":"Ehrchen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117243_b0190","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2019.01591","article-title":"Glucocorticoids shape macrophage phenotype for tissue repair","volume":"10","author":"Desgeorges","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCRESAHA.109.199505","article-title":"CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages","volume":"106","author":"Gleissner","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2023.117243_b0200","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1099\/vir.0.2008\/005009-0","article-title":"Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus","volume":"89","author":"Van Gorp","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cca.2023.117243_b0205","doi-asserted-by":"crossref","first-page":"51561","DOI":"10.1074\/jbc.M409629200","article-title":"Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region","volume":"279","author":"Madsen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117243_b0210","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1189\/jlb.0410235","article-title":"Tumor necrosis factor alpha-converting enzyme (TACE\/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163","volume":"88","author":"Etzerodt","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2023.117243_b0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semcdb.2008.11.002","article-title":"The \u201ca disintegrin and metalloprotease\u201d (ADAM) family of sheddases: physiological and cellular functions","volume":"20","author":"Reiss","year":"2009","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2023.117243_b0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2005.02.031","article-title":"Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes","volume":"39","author":"Timmermann","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2023.117243_b0225","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.72.4.711","article-title":"Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163","volume":"72","author":"Hintz","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2023.117243_b0230","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/art.20174","article-title":"Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis","volume":"50","author":"Baeten","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117243_b0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(02)03142-3","article-title":"Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect","volume":"526","author":"Frings","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2023.117243_b0240","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1006\/bbrc.2001.5845","article-title":"Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation","volume":"288","author":"Hogger","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2023.117243_b0245","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood-2009-02-204263","article-title":"The level of monocyte turnover predicts disease progression in the macaque model of AIDS","volume":"114","author":"Hasegawa","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117243_b0250","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/aid.2007.0193","article-title":"CD163\/CD16 coexpression by circulating monocytes\/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression","volume":"24","author":"Fischer-Smith","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cca.2023.117243_b0255","doi-asserted-by":"crossref","first-page":"e115226","DOI":"10.1371\/journal.pone.0115226","article-title":"Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?","volume":"9","author":"Castley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117243_b0260","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"Burdo","year":"2011","journal-title":"J. Infect Dis."},{"key":"10.1016\/j.cca.2023.117243_b0265","doi-asserted-by":"crossref","unstructured":"E.M. Wilson, A. Singh, K.H. Hullsiek, D. Gibson, W.K. Henry, K. Lichtenstein, N.F. Onen, E. Kojic, P. Patel, J.T. Brooks, I. Sereti, J.V. Baker, H.I.V.A.i.t.E.o.E.T.I. Study to Understand the Natural History of, Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection, J. Infect. Dis. 210 (2014) 1396-1406.","DOI":"10.1093\/infdis\/jiu275"},{"key":"10.1016\/j.cca.2023.117243_b0270","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/infdis\/jiw264","article-title":"Soluble CD163 and clinical outcomes in treated HIV infection: insights into mechanisms","volume":"214","author":"Hunt","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2023.117243_b0275","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","article-title":"Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1-infected individuals","volume":"214","author":"Knudsen","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2023.117243_b0280","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/QAD.0000000000001432","article-title":"Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection","volume":"31","author":"Kirkegaard-Klitbo","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.cca.2023.117243_b0285","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/cmi.2014.66","article-title":"Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection","volume":"12","author":"Liang","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0290","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2023.117243_b0295","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"Fitch","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2023.117243_b0300","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/jix082","article-title":"Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men","volume":"215","author":"Hanna","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2023.117243_b0305","doi-asserted-by":"crossref","first-page":"e0158169","DOI":"10.1371\/journal.pone.0158169","article-title":"Plasma CXCL10, sCD163 and sCD14 levels have distinct associations with antiretroviral treatment and cardiovascular disease risk factors","volume":"11","author":"Castley","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117243_b0310","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12288-013-0273-0","article-title":"Hemophagocytic syndrome in severe dengue Fever: a rare presentation","volume":"30","author":"Mitra","year":"2014","journal-title":"Indian J. Hematol. Blood Transfus"},{"key":"10.1016\/j.cca.2023.117243_b0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12098-019-03158-1","article-title":"Dengue associated hemophagocytic lymphohistiocytosis","volume":"87","author":"Chaitanya","year":"2020","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.cca.2023.117243_b0320","doi-asserted-by":"crossref","first-page":"E12363","DOI":"10.1073\/pnas.1813819115","article-title":"Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue","volume":"115","author":"Zanini","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.cca.2023.117243_b0325","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7150\/ijms.13680","article-title":"Macrophage activation syndrome-associated markers in severe dengue","volume":"13","author":"Ab-Rahman","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cca.2023.117243_b0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s40064-015-1463-z","article-title":"Dengue death with evidence of hemophagocytic syndrome and dengue virus infection in the bone marrow","volume":"4","author":"Ab-Rahman","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.cca.2023.117243_b0335","doi-asserted-by":"crossref","unstructured":"S.S. S, A.B. Pillai, V.S. Ramachandrappa, K. T, R. Dhodapkar, J. Kah, S. Rajendiran, Increased serum levels of macrophage activation marker sCD163 in Dengue patients, J Clin Virol, 86 (2017) 62-67.","DOI":"10.1016\/j.jcv.2016.10.009"},{"key":"10.1016\/j.cca.2023.117243_b0340","doi-asserted-by":"crossref","first-page":"e1009742","DOI":"10.1371\/journal.ppat.1009742","article-title":"Impaired function and delayed regeneration of dendritic cells in COVID-19","volume":"17","author":"Winheim","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cca.2023.117243_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691725","article-title":"Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype","volume":"12","author":"Trombetta","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0350","doi-asserted-by":"crossref","unstructured":"D. Wendisch, O. Dietrich, T. Mari, S. von Stillfried, I.L. Ibarra, M. Mittermaier, C. Mache, R.L. Chua, R. Knoll, S. Timm, S. Brumhard, T. Krammer, H. Zauber, A.L. Hiller, A. Pascual-Reguant, R. Mothes, R.D. Bulow, J. Schulze, A.M. Leipold, S. Djudjaj, F. Erhard, R. Geffers, F. Pott, J. Kazmierski, J. Radke, P. Pergantis, K. Bassler, C. Conrad, A.C. Aschenbrenner, B. Sawitzki, M. Landthaler, E. Wyler, D. Horst, C.-O.I. Deutsche, S. Hippenstiel, A. Hocke, F.L. Heppner, A. Uhrig, C. Garcia, F. Machleidt, S. Herold, S. Elezkurtaj, C. Thibeault, M. Witzenrath, C. Cochain, N. Suttorp, C. Drosten, C. Goffinet, F. Kurth, J.L. Schultze, H. Radbruch, M. Ochs, R. Eils, H. Muller-Redetzky, A.E. Hauser, M.D. Luecken, F.J. Theis, C. Conrad, T. Wolff, P. Boor, M. Selbach, A.E. Saliba, L.E. Sander, SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis, Cell, 184 (2021) 6243-6261 e6227.","DOI":"10.1016\/j.cell.2021.11.033"},{"key":"10.1016\/j.cca.2023.117243_b0355","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1165\/rcmb.2022-0107TR","article-title":"Insights from Transcriptomics: CD163(+) Profibrotic Lung Macrophages in COVID-19","volume":"67","author":"Bhattacharya","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cca.2023.117243_b0360","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.immuni.2021.03.005","article-title":"Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19","volume":"54","author":"Szabo","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2023.117243_b0365","doi-asserted-by":"crossref","unstructured":"C. Hartmann, A. Miggiolaro, J.D.S. Motta, L. Baena Carstens, C. Busatta Vaz De Paula, S. Fagundes Grobe, L. Hermann de Souza Nunes, G. Lenci Marques, P. Libby, L. Zytynski Moura, L. de Noronha, C. Pellegrino Baena, The Pathogenesis of COVID-19 Myocardial Injury: An Immunohistochemical Study of Postmortem Biopsies, Front Immunol, 12 (2021) 748417.","DOI":"10.3389\/fimmu.2021.748417"},{"key":"10.1016\/j.cca.2023.117243_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.152032","article-title":"The differential immune response in mild versus fatal SARS-CoV2 infection","volume":"61","author":"Suster","year":"2022","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.cca.2023.117243_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627548","article-title":"Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia","volume":"12","author":"Zingaropoli","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0380","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12026-022-09312-w","article-title":"The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis","volume":"70","author":"Volfovitch","year":"2022","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cca.2023.117243_b0385","doi-asserted-by":"crossref","unstructured":"G.A. Mostafa, H.M. Ibrahim, A. Al Sayed Shehab, Y.G.E. Gendy, D.M.M. Aly, G.A.H. Shousha, Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2, Eur J Pediatr, 181 (2022) 2299-2309.","DOI":"10.1007\/s00431-022-04398-8"},{"key":"10.1016\/j.cca.2023.117243_b0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.imlet.2022.11.003","article-title":"COVID-19 acute respiratory distress syndrome promotes a specific alternative macrophage polarization","volume":"251\u2013252","author":"Garnier","year":"2022","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cca.2023.117243_b0395","doi-asserted-by":"crossref","first-page":"e57121","DOI":"10.1371\/journal.pone.0057121","article-title":"The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies","volume":"8","author":"Davey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117243_b0400","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.braindev.2012.10.005","article-title":"Serum soluble CD163 levels in patients with influenza-associated encephalopathy","volume":"35","author":"Hasegawa","year":"2013","journal-title":"Brain Dev."},{"key":"10.1016\/j.cca.2023.117243_b0405","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.virusres.2018.05.021","article-title":"Expression of CD206 and CD163 on intermediate CD14(++)CD16(+) monocytes are increased in hemorrhagic fever with renal syndrome and are correlated with disease severity","volume":"253","author":"Li","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.cca.2023.117243_b0410","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/vim.2014.0112","article-title":"Soluble scavenger receptor CD163 is associated with severe acute kidney injury in patients with hantaan virus infection","volume":"28","author":"Zhang","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0415","doi-asserted-by":"crossref","first-page":"e112127","DOI":"10.1371\/journal.pone.0112127","article-title":"Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndrome","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117243_b0420","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.prp.2004.10.006","article-title":"Expression of CD163 in the liver of patients with viral hepatitis","volume":"201","author":"Hiraoka","year":"2005","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.cca.2023.117243_b0425","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1479-5876-12-60","article-title":"Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure","volume":"12","author":"Zhang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cca.2023.117243_b0430","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/infdis\/jiy331","article-title":"Macrophage activation marker soluble CD163 is a dynamic marker of liver fibrogenesis in human immunodeficiency virus\/hepatitis C virus coinfection","volume":"218","author":"Lidofsky","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2023.117243_b0435","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3748\/wjg.v19.i18.2818","article-title":"Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure","volume":"19","author":"Ye","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2023.117243_b0440","first-page":"1059","article-title":"Soluble CD163 and CD163 expression on monocytes associated with chronic hepatitis B inflammation and HBsAg loss","volume":"10","author":"Xie","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.cca.2023.117243_b0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jvh.12309","article-title":"Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus","volume":"22","author":"Dultz","year":"2015","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.cca.2023.117243_b0450","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.27129","article-title":"Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C","volume":"60","author":"Kazankov","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2023.117243_b0455","doi-asserted-by":"crossref","first-page":"e0270911","DOI":"10.1371\/journal.pone.0270911","article-title":"The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV\/HIV infected subjects","volume":"17","author":"Cairoli","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117243_b0460","doi-asserted-by":"crossref","first-page":"e0179400","DOI":"10.1371\/journal.pone.0179400","article-title":"Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon","volume":"12","author":"Mascia","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117243_b0465","first-page":"130","article-title":"Relationship of tumor-associated macrophage population detected by CD68 PG-M1, CD68 KP1, and CD163 with latent EBV infection and prognosis in classical hodgkin lymphoma","volume":"37","author":"Mavili","year":"2021","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.cca.2023.117243_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030579","article-title":"Macrophage infiltration correlates with genomic instability in classic hodgkin lymphoma","volume":"10","author":"Hancic","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2023.117243_b0475","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ijc.27314","article-title":"Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection","volume":"131","author":"Barros","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2023.117243_b0480","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3324\/haematol.2010.031542","article-title":"Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma","volume":"96","author":"Kamper","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2023.117243_b0485","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2016.199","article-title":"Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma","volume":"30","author":"Morscio","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cca.2023.117243_b0490","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1182\/blood-2018-08-870915","article-title":"Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study","volume":"133","author":"Hsi","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117243_b0495","first-page":"492","article-title":"Expression of CD163 in children with Epstein-Barr virus infection","volume":"17","author":"Chen","year":"2015","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.cca.2023.117243_b0500","doi-asserted-by":"crossref","first-page":"e0198174","DOI":"10.1371\/journal.pone.0198174","article-title":"Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection","volume":"13","author":"Mascia","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117243_b0505","doi-asserted-by":"crossref","unstructured":"D.E. Nixon, R.J. Bosch, E.S. Chan, N.T. Funderburg, S. Hodder, J.E. Lake, M.M. Lederman, K.L. Klingman, J.A. Aberg, Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130mg\/dL (AIDS Clinical Trials Group Study A5275), J Clin Lipidol, 11 (2017) 61-69.","DOI":"10.1016\/j.jacl.2016.09.017"},{"key":"10.1016\/j.cca.2023.117243_b0510","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/infdis\/jiv004","article-title":"Differential reduction in monocyte activation and vascular inflammation with integrase inhibitor-based initial antiretroviral therapy among HIV-infected individuals","volume":"212","author":"Hileman","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2023.117243_b0515","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/infdis\/jiaa635","article-title":"Human immunodeficiency Virus Type 1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy: inflammation and immune cell modulation","volume":"223","author":"Luscombe","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2023.117243_b0520","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2016.12.010","article-title":"Systemic inflammation before and after antiretroviral therapy initiation as a predictor of immune response among HIV-infected individuals in Manitoba","volume":"91","author":"Richert","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2023.117243_b0525","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/infdis\/jiy337","article-title":"Normalization of soluble CD163 levels after institution of antiretroviral therapy during acute HIV infection tracks with fewer neurological abnormalities","volume":"218","author":"D'Antoni","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2023.117243_b0530","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66125","article-title":"An open label trial of anakinra to prevent respiratory failure in COVID-19","volume":"10","author":"Kyriazopoulou","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.cca.2023.117243_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.871592","article-title":"Role of tocilizumab in down regulating sCD163 plasmatic levels in a cohort of COVID-19 patients","volume":"13","author":"Marocco","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0540","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/00365521.2018.1481996","article-title":"Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology","volume":"53","author":"Lund Laursen","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.cca.2023.117243_b0545","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/jvh.12488","article-title":"The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients","volume":"23","author":"Dultz","year":"2016","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.cca.2023.117243_b0550","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00430-018-0538-1","article-title":"Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment","volume":"207","author":"Parisi","year":"2018","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.cca.2023.117243_b0555","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"Moller","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117243_b0560","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2362.2009.02170.x","article-title":"Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity","volume":"39","author":"Sporrer","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cca.2023.117243_b0565","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/ijo.2009.160","article-title":"Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance","volume":"33","author":"Shakeri-Manesch","year":"2009","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.cca.2023.117243_b0570","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.107.149435","article-title":"Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2\u20132 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability","volume":"101","author":"Levy","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2023.117243_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"Moller","year":"2012","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2023.117243_b0580","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/infdis\/jiaa254","article-title":"Hepatitis C virus (HCV) direct-acting antiviral therapy in persons with human immunodeficiency virus-HCV genotype 1 coinfection resulting in high rate of sustained virologic response and variable in normalization of soluble markers of immune activation","volume":"222","author":"Anthony","year":"2020","journal-title":"J. Infect. Dis."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:07:06Z","timestamp":1757862426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":116,"alternative-id":["S0009898123000451"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117243","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical utility of CD163 in viral diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117243"}}